C4 Therapeutics, Inc.CCCCNASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
73.76%
↑ 164% above average
Average (26q)
27.98%
Historical baseline
Range
High:315.62%
Low:-70.55%
Volatility
1379.9%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 73.76% |
| Q2 2025 | -10.71% |
| Q1 2025 | 39.81% |
| Q4 2024 | -66.30% |
| Q3 2024 | 27.95% |
| Q2 2024 | 295.06% |
| Q1 2024 | -6.81% |
| Q4 2023 | -70.55% |
| Q3 2023 | 315.62% |
| Q2 2023 | -29.13% |
| Q1 2023 | 31.71% |
| Q4 2022 | -57.74% |
| Q3 2022 | -51.18% |
| Q2 2022 | 80.74% |
| Q1 2022 | -61.88% |
| Q4 2021 | 136.21% |
| Q3 2021 | -13.10% |
| Q2 2021 | 31.71% |
| Q1 2021 | -10.12% |
| Q4 2020 | -2.19% |
| Q3 2020 | -12.65% |
| Q2 2020 | 41.87% |
| Q1 2020 | -16.97% |
| Q4 2019 | 53.04% |
| Q3 2019 | 37.42% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |